Clinical Trial Update: A Study of EPEG in Beta Thalassemia Patients [Phase 1]

View source ↗

Summary

Phase 1 study of EPEG in beta-thalassemia patients has completed; results are not described in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• EPEG

Snippet

Sponsor: Prolong Pharmaceuticals | Conditions: Beta-Thalassemia | Phase 1 | Status: COMPLETED